Inferring Diagnostic and Prognostic Gene Expression Signatures Across WHO Glioma Classifications: A Network-Based Approach
Tumor heterogeneity is a challenge to designing THIN/FINE CONDITIONER effective and targeted therapies.Glioma-type identification depends on specific molecular and histological features, which are defined by the official World Health Organization (WHO) classification of the central nervous system (CNS).These guidelines are constantly updated to sup